Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
about
Current advances in Phi29 pRNA biology and its application in drug deliveryReceptor binding peptides for target-selective delivery of nanoparticles encapsulated drugsA review of current nanoparticle and targeting moieties for the delivery of cancer therapeuticsNanoparticle ligand presentation for targeting solid tumorsSynthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatmentTargeting and Photodynamic Killing of Cancer Cell by Nitrogen-Doped Titanium Dioxide Coupled with Folic AcidGold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to Near-Infrared Light and Redox Potential as a Theranostic Platform for Cancer Therapy.Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects.Magnetoliposomes loaded with poly-unsaturated fatty acids as novel theranostic anti-inflammatory formulationsTargeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics.Peptide-mediated cellular uptake of cryptophane.Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.Avidity mechanism of dendrimer-folic acid conjugates.Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted deliveryEnhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.End-functionalized polymers and junction-functionalized diblock copolymers via RAFT chain extension with maleimido monomers.Self-assembled lipid nanomedicines for siRNA tumor targeting.Enzyme-directed assembly of a nanoparticle probe in tumor tissueTargeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approachLiposomal nanostructures for photosensitizer delivery.Bioengineering strategies for designing targeted cancer therapiesTherapeutic targeting of a novel 6-substituted pyrrolo [2,3-d]pyrimidine thienoyl antifolate to human solid tumors based on selective uptake by the proton-coupled folate transporterA reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligandsTargeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumors.Polymersomes as an effective drug delivery system for glioma--a review.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Targeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT)The role of flexible tethers in multiple ligand-receptor bond formation between curved surfaces.Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma.Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancerAssessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan.Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism.Dual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatment.Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes.Cryptophane-folate biosensor for (129)xe NMR.Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.
P2860
Q26828745-F3E16102-D95C-41BD-8D97-166598F88134Q26849241-6E2B8578-E186-4394-84ED-39B501564BADQ27006569-869A986C-DC2B-4397-8141-66446AF2E115Q27009522-0CB4E4BC-3FCB-4F3F-BBF4-FA6B22FA8BD8Q28487569-FB65B40C-6AE7-4D4E-AE9F-9C3117F1285EQ29248436-C95F5294-33E8-4F25-8025-BDF0E6227736Q30353920-113D2B7F-A5A7-4337-A1CB-523051F73326Q30483431-A61A9E26-667A-4134-A777-2BB94E201070Q30909702-D575FAD6-D79E-43C6-B4A2-2184D8BF3077Q31169933-6826057A-A64E-4B05-B124-345EC8E7E7FCQ33262142-98D7A4EE-E648-446F-BE60-FB029EF9FFCDQ33377228-9D140BC2-F5CA-41B6-8F60-EBC4A212DCDBQ33549485-C1F3C736-20FF-4A55-B725-FEF3876C1B22Q33598717-FA2056C0-0034-43AB-9226-4AAF46B50638Q33604955-6C0AC045-382F-46D5-B1B8-38F65FA05F8FQ33631805-24BD2AAF-148A-4DD6-AFD9-B1FF18A6A621Q33640942-0677E898-93AE-4C0B-81D2-877D154063CCQ33882801-681E5038-29A7-49C0-9EFC-88D76B394644Q33907349-FA5780D3-46F9-48A7-BA57-9730BF4635B6Q33907953-A994950B-A038-4DC3-9380-98D89A0E7A22Q33940322-66E35893-EAFE-449B-A4DC-268273E2B1C2Q33941281-35AFF1D3-AF1C-4CE6-9633-6D2BCADEEA8FQ34068206-FAF6674F-10C5-4E1D-AA08-BE28F976E625Q34194191-6DA76303-55B3-4BD2-ABC7-9A31A76907F7Q34218576-8B75F22A-B5C8-4914-9ED8-726EBB72EA43Q34242570-FAE78AAD-82D4-44F6-A18E-8C9B15D245E0Q34310128-0BE55DA7-0D17-4999-9C24-7A75CC9018F7Q34420100-67C3B6F6-1B8F-4532-90C8-5A03A7829D0AQ34447986-BE176502-784E-4210-91C8-F565FF6D7274Q34927053-584BBBD8-AEBF-4603-B070-0FE992E71A0CQ34984732-15CC8913-9D40-48D0-B4AE-6224C5D44579Q35027211-0559471B-1B3A-42C4-BF6E-8194C7E7791DQ35047386-FE598967-14C3-4681-8FBB-3E9BD75A3119Q35129324-16757278-B5E1-4238-A634-D4449D5C63A4Q35201491-E39DB6E1-6D91-4D1E-8D1F-1F9A3EC71C9AQ35234731-7D9C7BFF-EDEA-44CF-8834-A4498CDCFA43Q35236160-97404BEA-936A-47A9-B5EF-130A08E9C0C4Q35300570-F0B88ED0-F155-4F9E-B17F-D82ED9FE0E2AQ35464342-DEC4AB84-BC92-417F-B37F-E9A170F90199Q35624762-8BDC16A7-C287-4309-A938-EA0D221EAD3B
P2860
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@ast
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@en
type
label
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@ast
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@en
prefLabel
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@ast
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@en
P356
P1476
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
@en
P2093
Andrew R Hilgenbrink
Philip S Low
P304
P356
10.1002/JPS.20457
P407
P577
2005-10-01T00:00:00Z